FDA Inspection 1166625 — John D. Gabriel, MD
The FDA completed an inspection of John D. Gabriel, MD on March 25, 2022 in North Richland Hills, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 25, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- North Richland Hills, TX (United States)
Additional Details
Clinical Investigator (CI)